National Health Investors Inc
NYSE:NHI

Watchlist Manager
National Health Investors Inc Logo
National Health Investors Inc
NYSE:NHI
Watchlist
Price: 80.17 USD -0.32% Market Closed
Market Cap: 3.8B USD
Section:
 

Relative Value

The Relative Value of one NHI stock under the Base Case scenario is 97.93 USD. Compared to the current market price of 80.17 USD, National Health Investors Inc is Undervalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NHI Relative Value
Base Case
97.93 USD
Undervaluation 18%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

10.7
P/S
P/S
Price to Sales
10.7
vs History
1
vs Industry
15
Median 3Y
8.8
Median 5Y
7.9
Industry
3.9
Forward
10.8
More Details
26
P/E
P/E
Price to Earnings
26
vs History
20
vs Industry
21
Median 3Y
23.7
Median 5Y
22.5
Industry
16.5
Forward
26
More Details
16.9
P/OCF
P/OCF
Price to OCF
16.9
vs History
3
vs Industry
22
Median 3Y
14.2
Median 5Y
12.1
Industry
11.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
2
Median 3Y
26.5
Median 5Y
18.3
Industry
12.9
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
6
vs Industry
12
Median 3Y
2.2
Median 5Y
1.7
Industry
0.9
More Details
13.6
EV/S
EV/S
Enterprise Value to Sales
13.6
vs History
4
vs Industry
18
Median 3Y
12.2
Median 5Y
11.9
Industry
6.9
Forward
13.7
More Details
16.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
16.4
vs History
3
vs Industry
30
Median 3Y
14.6
Median 5Y
13
Industry
12.6
More Details
18.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
18.2
vs History
1
vs Industry
34
Median 3Y
15.9
Median 5Y
14.5
Industry
16
Forward
16.8
More Details
25.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25.8
vs History
0
vs Industry
28
Median 3Y
22.5
Median 5Y
21.3
Industry
19.4
Forward
23.7
More Details
21.4
EV/OCF
EV/OCF
Enterprise Value to OCF
21.4
vs History
11
vs Industry
30
Median 3Y
20
Median 5Y
18.3
Industry
18.8
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
8
Median 3Y
22.7
Median 5Y
20.7
Industry
21.1
More Details
1.9
EV/IC
EV/IC
Enterprise Value to IC
1.9
vs History
1
vs Industry
9
Median 3Y
1.6
Median 5Y
1.4
Industry
0.8
More Details

Multiples Across Competitors

NHI Competitors Multiples
National Health Investors Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
National Health Investors Inc
NYSE:NHI
3.8B USD 10.7 26 18.2 25.8
US
Welltower Inc
NYSE:WELL
130.9B USD 13.2 136.3 38.7 86.8
US
Ventas Inc
NYSE:VTR
36.8B USD 6.6 154.7 21.8 53.3
US
Omega Healthcare Investors Inc
NYSE:OHI
13.2B USD 11.5 25.3 16.8 24.3
US
Physicians Realty Trust
NYSE:DOC
12.4B USD 4.4 -318.3 13.6 42.1
US
Healthpeak Properties Inc
F:HC5
10.6B EUR 4.4 -316.9 13.5 41.9
US
CareTrust REIT Inc
NYSE:CTRE
8.4B USD 19.6 32.3 23.5 30.2
US
Healthcare Trust Of America Inc
F:HT01
5.3B EUR 7.9 65.4 19.9 51.2
US
Healthcare Realty Trust Inc
NYSE:HR
6.1B USD 5 -16.4 16.1 172.4
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
4.8B USD 6.4 27.4 16.2 27
BE
Aedifica NV
XBRU:AED
3.6B EUR 10 15.7 19.6 19.8
P/E Multiple
Earnings Growth PEG
US
National Health Investors Inc
NYSE:NHI
Average P/E: 60.4
26
6%
4.3
US
Welltower Inc
NYSE:WELL
136.3
28%
4.9
US
Ventas Inc
NYSE:VTR
154.7
79%
2
US
Omega Healthcare Investors Inc
NYSE:OHI
25.3
12%
2.1
US
Physicians Realty Trust
NYSE:DOC
Negative Multiple: -318.3
-7%
N/A
US
H
Healthpeak Properties Inc
F:HC5
Negative Multiple: -316.9
-7%
N/A
US
C
CareTrust REIT Inc
NYSE:CTRE
32.3
44%
0.7
US
H
Healthcare Trust Of America Inc
F:HT01
65.4
N/A N/A
US
Healthcare Realty Trust Inc
NYSE:HR
Negative Multiple: -16.4 N/A N/A
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
27.4
18%
1.5
BE
Aedifica NV
XBRU:AED
15.7
8%
2

See Also

Summary
NHI intrinsic value, competitors valuation, and company profile.
DCF Valuation
NHI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NHI stock valuation using valuation multiples.
Wall Street Estimates
NHI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NHI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 310,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.